OccuRx

OccuRx

Primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.

HQ location
Melbourne, Australia
Website
occurx.com
Launch date
Employees
2-10 people
Enterprise value
$38—56m
Company register number
164284440
https://twitter.com/occurxbiotechhttps://www.linkedin.com/company/occurx/
    • Edit
loading funding rounds…
Uniseed Ventures
Uniseed Ventures(exited)
Brandon Capital Partners
Brandon Capital Partners(exited)
Brandon BioCatalyst
Brandon BioCatalyst(exited)
CUREator
CUREator(exited)
Innovation Connections
Innovation Connections(exited)
Stoic Venture Capital
Stoic Venture Capital(exited)
Certa Therapeutics
Certa Therapeutics
University of Melbourne
University of Melbourne

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo